Semper Paratus
is headquartered in New York, New York. Semper Paratus's parent company has been Tevogen Bio Holdings Inc. since Feb 2024. Semper Paratus's IPO generated $345M. Semper Paratus has 1 followers on Owler. Semper Paratus has an estimated revenue of <$1M and an estimate of less <10 employees.Semper Paratus
is headquartered in New York, New York. Semper Paratus's parent company has been Tevogen Bio Holdings Inc. since Feb 2024. Semper Paratus's IPO generated $345M. Semper Paratus has 1 followers on Owler. Semper Paratus has an estimated revenue of <$1M and an estimate of less <10 employees.
News
Feb 14, 2024
BioSpace
Semper Paratus: Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN
Feb 01, 2024
Zephyr Net
Semper Paratus: Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal | SPAC Feed
Sep 29, 2023
StreetInsider
Press Release: Semper Paratus : Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement
Sep 14, 2023
StreetInsider
Press Release: Semper Paratus : Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc
Jun 30, 2023
ChinaPulse
Semper Paratus: Tevogen to go public via merger with SPAC Semper Paratus
Dec 30, 2021
MarketScreener
Semper Paratus: Semper Paratus Acquisition : Announces the Separate Trading of its Class A Ordinary Shares and Warrants - Form 8-K
Nov 08, 2021
MarketScreener
Semper Paratus: Semper Paratus Acquisition Corporation Announces Closing of $345 Million Initial Public Offering